BR100 Increased By (1.37%)
BR30 Increased By (1.26%)
KSE100 Increased By (1.16%)
KSE30 Increased By (1.21%)
AGHA 7.84 Increased By ▲ 0.09 (1.16%)
BECO 5.24 Increased By ▲ 0.05 (0.96%)
BML 57.90 Decreased By ▼ -0.76 (-1.3%)
BOP 34.40 Increased By ▲ 0.71 (2.11%)
CNERGY 10.92 Increased By ▲ 0.31 (2.92%)
CSIL 5.45 Increased By ▲ 0.15 (2.83%)
FCCL 55.00 Increased By ▲ 1.26 (2.34%)
FFL 16.80 Increased By ▲ 0.34 (2.07%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.84 Increased By ▲ 0.20 (3.55%)
LOTCHEM 30.00 Increased By ▲ 0.35 (1.18%)
MLCF 96.97 Increased By ▲ 0.61 (0.63%)
NBP 206.20 Increased By ▲ 2.67 (1.31%)
NCPL 58.00 Increased By ▲ 1.15 (2.02%)
NPL 68.80 Increased By ▲ 1.49 (2.21%)
OGDC 320.50 Increased By ▲ 2.28 (0.72%)
PACE 10.92 Increased By ▲ 0.29 (2.73%)
PAEL 43.35 Increased By ▲ 1.58 (3.78%)
PIBTL 17.09 Increased By ▲ 0.28 (1.67%)
PPL 223.12 Increased By ▲ 2.95 (1.34%)
PRL 52.38 Increased By ▲ 3.33 (6.79%)
PTC 71.53 Increased By ▲ 1.52 (2.17%)
SSGC 29.70 Increased By ▲ 0.56 (1.92%)
TBL 9.93 Increased By ▲ 0.16 (1.64%)
TELE 8.97 Increased By ▲ 0.15 (1.7%)
TPL 17.85 Increased By ▲ 0.68 (3.96%)
TPLP 13.05 Increased By ▲ 0.54 (4.32%)
TREET 22.92 Increased By ▲ 0.33 (1.46%)
TRG 60.35 Increased By ▲ 0.13 (0.22%)

ISLAMABAD: The Competition Appellate Tribunal (CAT) has upheld the cumulative penalty of Rs 40 million imposed by the Competition Commission of Pakistan (CCP) on United Distributors Pakistan Limited (UDPL) and International Brands (Private) Limited (IBL) for entering into an anti-competitive non-compete agreement in violation of Section 4 of the Competition Act, 2010.

In its order, the Tribunal affirmed that the appellants, by their own conduct, acknowledged the agreement as a non-compete arrangement and endorsed the CCP’s finding that the agreement restricted competition and constituted a prohibited market-sharing arrangement.

The CCP had initiated proceedings after UDPL publicly disclosed to the Pakistan Stock Exchange that it had entered into a non-compete agreement with IBL. Under the agreement, UDPL agreed not to distribute human pharmaceutical products in Pakistan for a period of three years in exchange for a payment of PKR 1.131 billion from IBL.

The CCP found that the agreement effectively eliminated UDPL as a competitor in the relevant market and restricted competition. The substantial payment was deemed a financial incentive to ensure UDPL’s exit from the market, thereby protecting IBL from competitive pressure and creating barriers to entry. Although the agreement contained a clause requiring regulatory approval, both companies failed to obtain prior exemption from the CCP and applied for exemption only after the issuance of show-cause notices. CCP rejected the exemption application, concluding that the agreement did not meet the legal criteria for exemption and that the violation had already occurred.

Accordingly, the CCP imposed a penalty of PKR 20 million each on UDPL and IBL under Section 38 of the Competition Act, 2010, for entering into and giving effect to the anti-competitive agreement. The Tribunal upheld the CCP’s findings on the violation. It endorsed the CCP’s view that, following the dismissal of their exemption application, the appellants did not pursue any further legal remedy, thereby implying acceptance of the contravention. The Tribunal held that the penalties of PKR 20 million each imposed on UDPL and IBL were justified and warranted, and accordingly maintained the cumulative penalty of PKR 40 million.

Copyright Business Recorder, 2026

Comments

200 characters remaining